Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 65 of 1402 for:    Peru

Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03988738
Recruitment Status : Recruiting
First Posted : June 17, 2019
Last Update Posted : July 12, 2019
Sponsor:
Information provided by (Responsible Party):
Joel Gustavo Rondón Rodríguez, Universidad Peruana Cayetano Heredia

Brief Summary:

Blood donations are an important need worldwide. In Peru, only 10% of donations are voluntary, of which only a quarter are repeat donors. Repeat donations are crucial to maintaining a safe and adequate blood supply.

Social media presents a unique opportunity to promote blood donation, because of its increasing use and its prior successes in promoting positive health-related behaviors .

The present study aims to develop and evaluate a social media intervention - Facebook and WhatsApp - to improve communication and promote repeat blood donations in voluntary first-time donors attending donation campaigns organized by the Hospital Nacional Cayetano Heredia (HCH).


Condition or disease Intervention/treatment Phase
Blood Donors Other: Social Media Publications Not Applicable

Detailed Description:

Main Objective:

To evaluate the effect of social media in the promotion of repeat blood donation among first-time blood donors in a Peruvian blood bank.

Study design:

A randomized control trial will be conducted over a 6-month period, and will compare the rate of repeat blood donation who amongst first-time donors who received promotional messages through social media and those who did not.

Population:

Voluntary first-time blood donors who attend blood donation campaigns organized by the blood bank of the Hospital Nacional Cayetano Heredia (HCH), Lima - Peru.

Sample:

A sample of 105 participants per group was calculated, with a significance of 95% and a power of 80%, to show a difference of 20% in recurrence rate of blood donation between the two groups.

Group assignment:

Participant selection will occur at blood donation campaigns organized by the HCH blood bank. If inclusion and exclusion criteria are met, donors will be invited to participate in the study. After accepting and signing the informed consent form, donors will be randomly assigned to one of two groups using complete block randomization until a total of 212 participants are recruited: 106 in the intervention group and 106 in the control group. All participants will receive an introductory message through social media confirming their participation in the study.

Ethical considerations:

Written informed consent will be requested from participants. Data confidentiality will be maintained. Personal identifiers will be stored in a separate database, which will be password protected and accessible only to the research team.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 212 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Donors will be randomly assigned to one of two groups using complete block randomization until a total of 212 participants are recruited: 106 in the intervention group and 106 in the control group.
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Other
Official Title: Social Media-based Intervention to Promote Repeat Blood Donation Among First-time Blood Donors in a Peruvian Blood Bank: Randomized Controlled Trial
Actual Study Start Date : June 20, 2019
Estimated Primary Completion Date : December 20, 2019
Estimated Study Completion Date : December 20, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention
Participants will receive messages regarding blood donation promotion and campaigns through social media once or twice a week for six months.
Other: Social Media Publications
Messages will be elaborated prior to participant enrollment. Messages will be evaluated by three experts.

Sham Comparator: Control
Participants will receive a message regarding blood donation at the beginning of the study through social media. After four months they will receive another message including information about upcoming blood donation campaigns.
Other: Social Media Publications
Messages will be elaborated prior to participant enrollment. Messages will be evaluated by three experts.




Primary Outcome Measures :
  1. Repeat Blood donation rate [ Time Frame: 6 months ]
    Rate of repeat blood donation will be assessed in both groups after intervention.


Secondary Outcome Measures :
  1. Time interval between blood donations [ Time Frame: 6 months ]
    Time interval between blood donations will be evaluated in both groups.

  2. Readiness to Change [ Time Frame: 6 months ]
    Apply Transtheoretical Model of Change to assess first-time donors´ readiness to change.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Voluntary first-time Blood Donor
  • Eligible to donate blood again
  • Facebook or WhatsApp user

Exclusion Criteria:

  • Denial to participate in the study
  • Refusal to be contacted by social media

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03988738


Contacts
Layout table for location contacts
Contact: Joel G Rondon Rodriguez, MD +51 958 584 300 joel.rondon@upch.pe
Contact: Isaac E Alva Lopez, MPH +51 947 421 909 isaac.alva.l@upch.pe

Locations
Layout table for location information
Peru
Hospital Nacional Cayetano Heredia Blood Bank Recruiting
San Martín De Porres, Lima, Peru, 15102
Contact: Belinda M Arias Guzman, MT    +51 994 308 075    belinda.arias.g@upch.pe   
Contact: Julio A Vidal Escudero, MD    +51 999 956 564    julio.vidal@upch.pe   
Sponsors and Collaborators
Universidad Peruana Cayetano Heredia
Investigators
Layout table for investigator information
Principal Investigator: Joel G Rondon Rodriguez, MD Universidad Peruana Cayetano Heredia

Publications:
World Health Organization, International Federation of Red Cross and Red Crescent Societies. Towards 100% voluntary blood donation: A global framework for action [Internet]. Geneva: WHO; 2010 [cited 2019 Jan 29]. Available from: https://www.who.int/bloodsafety/publications/9789241599696_eng.pdf
Dirección General de Donaciones Trasplantes y Banco de Sangre. Peruvian National Plan for Voluntary Blood Donor Promotion 2018 - 2021 [Internet]. Lima: Peru Ministry of Health; 2018 p. 16. Available from: ftp://ftp2.minsa.gob.pe/normaslegales/2018/Resolucion_Ministerial_672-2018-MINSA.pdf

Layout table for additonal information
Responsible Party: Joel Gustavo Rondón Rodríguez, Researcher, Universidad Peruana Cayetano Heredia
ClinicalTrials.gov Identifier: NCT03988738     History of Changes
Other Study ID Numbers: 103806
First Posted: June 17, 2019    Key Record Dates
Last Update Posted: July 12, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Joel Gustavo Rondón Rodríguez, Universidad Peruana Cayetano Heredia:
Blood Donors
Social Media
Blood Donation
Facebook
WhatsApp